Oligonucleotide Therapeutics: From Discovery and Development to Patentability

Following the first proof of concept of using small nucleic acids to modulate gene expression, a long period of maturation led, at the end of the last century, to the first marketing authorization of an oligonucleotide-based therapy. Since then, 12 more compounds have hit the market and many more ar...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Lara Moumné, Anne-Céline Marie, Nicolas Crouvezier
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2022-01-01
Cyfres:	Pharmaceutics
Pynciau:	oligonucleotides antisense small interfering RNA exon skipping small activating RNA microRNA
Mynediad Ar-lein:	https://www.mdpi.com/1999-4923/14/2/260
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!